BSF Enterprise Plc (LON:BSFA)

London flag London · Delayed Price · Currency is GBP · Price in GBX
1.800
+0.300 (20.00%)
Apr 24, 2026, 4:22 PM GMT
Market Cap2.92M +71.8%
Revenue (ttm)52.84K -8.6%
Net Income-1.11M
EPS-0.11
Shares Out166.87M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,841,569
Average Volume7,420,207
Open1.587
Previous Close1.500
Day's Range1.365 - 2.140
52-Week Range0.500 - 4.000
Beta3.14
RSI53.11
Earnings DateJun 26, 2026

About BSF Enterprise

BSF Enterprise Plc, together with its subsidiaries, develops and commercializes cell-based tissue engineering solutions in the United Kingdom and Hong Kong. The company acquires businesses in the biotechnology, marketing, and e-commerce sectors. It also engages in biotechnology start-up; lab-grown cornea and meat research; and development of skin technology. The company was incorporated in 2018 and is based in London, the United Kingdom. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Employees 14
Stock Exchange London Stock Exchange
Ticker Symbol BSFA
Full Company Profile

Financial Performance

In fiscal year 2025, BSF Enterprise's revenue was 52,840, a decrease of -8.61% compared to the previous year's 57,821. Losses were -1.11 million, -33.41% less than in 2024.

Financial Statements

News

BSF Enterprise PLC Announces Participation in The ThinkEquity Conference

London, United Kingdom--(Newsfile Corp. - October 5, 2023) - BSF Enterprise PLC (LSE: BSFA) (OTCQB: BSFAF), a company focused on unlocking the next generation of biotechnological solutions using cell-...

2 years ago - Newsfile Corp

BSF Enterprise PLC Provides City-MixTM Bio-Pharmaceutical Update

LONDON, July 18, 2023 (GLOBE NEWSWIRE) -- BSF Enterprise PLC ("BSF" or the "Company") (LSE: BSFA), (OTCQB: BSFAF), a company focused on unlocking the next generation of biotechnological solutions usin...

3 years ago - GlobeNewsWire